Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma

JAMA Oncol. 2021 May 1;7(5):773-775. doi: 10.1001/jamaoncol.2021.0019.

Abstract

This cohort study examines treatment with immune checkpoint inhibitors for patients with metastatic renal cell carcinoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Mass Index
  • Carcinoma, Renal Cell* / drug therapy
  • Carcinoma, Renal Cell* / genetics
  • Genomics
  • Humans
  • Immune Checkpoint Inhibitors
  • Kidney Neoplasms* / drug therapy
  • Kidney Neoplasms* / genetics

Substances

  • Immune Checkpoint Inhibitors